Related Experiment Video
Updated: Jul 18, 2026

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
Published on: May 31, 2017
Acute fulminant myocarditis after diphtheria, polio, and tetanus vaccination
Shye-Jao Wu1, Shen Sun, Jiun-Yi Li
1Division of Cardiovascular Surgery, Department of Surgery, MacKay Memorial Hospital, Taipei, Taiwan. wsj003@med-assn.org.tw
Insights
A rare case of acute fulminant myocarditis in an infant followed a diphtheria, polio, and tetanus vaccination. Despite initial survival with extracorporeal membrane oxygenation, the infant later died from heart failure.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Vaccinations are crucial for preventing infectious diseases in infants.
- Myocarditis, inflammation of the heart muscle, can have severe consequences.
Observation:
- An infant developed acute fulminant myocarditis, characterized by fever and dyspnea, post-vaccination.
- The infant required extracorporeal membrane oxygenation (ECMO) for profound cardiogenic shock.
Findings:
- The patient survived ECMO but experienced recurrent ventricular dysfunction two months later.
- The infant ultimately died while awaiting a heart transplant.
Implications:
- This case highlights a potential, albeit rare, adverse cardiac event following vaccination.
- Further investigation into vaccine-associated myocarditis in infants is warranted.
- Understanding such events is critical for vaccine safety monitoring and risk-benefit assessments.
Abstract:
We report an infant case of acute fulminant myocarditis which occurred after administration of a diphtheria, polio, and tetanus vaccination. Fever and dyspnea developed after the vaccination. Extracorporeal membrane oxygenation was used for intractable cardiogenic shock. The patient survived the extracorporeal support, but poor ventricular contractility recurred 2 months later and she died while waiting for heart transplantation.
Related Concept Videos
Diphtheria
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Poliomyelitis
Rheumatic Heart Disease I: Introduction